293T cells were seeded on 96 well plates (1.5x104 cells/well). When confluent, media was removed and 50 µL of Opti-MEM added to each well. Two µL Opti-MEM added per well with the following plasmid quantities: 12, 6 or 1 ng E1E2 or sE2 plasmid (nanogram quantity equalised with pCDNA between conditions), 6 ng LTR and 1 ng Tat. PEI was diluted to 0.14 µg/µl in 200 µL Opti-MEM and 2 µL of the diluted PEI was added to the plasmid mix. The plasmid/PEI mix was incubated at rt for 30 min before being added to cells and incubating for 6 h at 5% CO2/37°C after which Opti-MEM/plasmid mix was removed and 250 µL DMEM added. Plates were measured for luciferase activity 48 h after transfection as described above. The following genotypes of HCV E1E2 Env were used – 1a, 1b, 2b, 3, 4, 5 and 6 (44, 45). HCV sE2 plasmids containing the gene fragment for the soluble ectodomain of the HCV E2 protein (aa363-661, referenced to the HCV strain H77 polyprotein) were PCR amplified from full length E1/E2 plasmids using genotype-specific primers [primer sequences described previously (45)] and Expand High-Fidelity Polymerase PCR System (Roche). PCR products were sub-cloned into the pCDNA plasmid and possessed an in-frame C-terminal 6xHis tag sequence. The following genotypes of HCV sE2 envelope were used – 1a, 1b, 2b, 4, 5 and 6. No corresponding sE2 genotype 3a plasmid was available.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.